OSI Systems/ US6710441055 /
2024-07-26 9:59:55 PM | Chg. +2.89 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
150.36USD | +1.96% | 2,132 Turnover: 319,020.26 |
-Bid Size: - | -Ask Size: - | 2.56 bill.USD | - | 27.58 |
GlobeNewswire
05-10
Open Space Institute Holds 50th Anniversary Gala Honoring Founders John & Patricia Adams and Longtim...
GlobeNewswire
04-30
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patien...
GlobeNewswire
03-19
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie
GlobeNewswire
03-18
BIVI 4-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages BioVie (BIVI) Investo...
GlobeNewswire
03-17
BIOVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has...
GlobeNewswire
03-15
BIVI 4-DAY DEADLINE ALERT: Hagens Berman Encourages BioVie (BIVI) Investors with Substantial Losses ...
GlobeNewswire
03-14
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioV...
GlobeNewswire
03-14
TUESDAY DEADLINE: Berger Montague Advises BioVie Inc. (NASDAQ: BIVI) Investors to Inquire About a Se...
GlobeNewswire
03-14
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mob...
GlobeNewswire
03-12
BioVie (BIVI) Faces Securities Fraud Class Action After Uncovering Potential Scientific Misconduct I...
GlobeNewswire
03-10
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mob...
GlobeNewswire
03-07
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioV...
GlobeNewswire
03-06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
03-02
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
03-01
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bi...
GlobeNewswire
02-27
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
02-23
Investors Sue BioVie (BIVI) After Potential Scientific Misconduct In Failed Phase 3 Clinical Trial U...
GlobeNewswire
02-23
BIOVIE SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encoura...
GlobeNewswire
02-23
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...